EVENTS
FAQ
DONATE
CONTACT PIH
Who We AreWhat We DoWhere We WorkIssues We FaceWhat You Can DoInformation Resources
ISSUES WE FACE
HIV/AIDS
TUBERCULOSIS
WOMEN'S HEALTH
CHILD HEALTH
FOOD, WATER, HOUSING
COMMUNITY HEALTH WORKERS


TB AND MDR-TB
CROSS-REFERENCE
- INFORMATION RESOURCES


PIH Manual - TBTHE PIH GUIDE TO THE COMMUNITY-BASED TREATMENT OF MDR TB


 
Tuberculosis information resources

books | essays | newsletter articles | research articles | recommended reading

Books

Tuberculosis control: Financial Evaluation For the 2001 - 2005 Period in Low and Lower Middle-income Countries: Economic Annex to the Global Plan to Stop TB
by Olivier Appaix
Partners In Health (June, 2003)

PIH Guide to the Medical Management of Multidrug-Resistant Tuberculosis
This guide is intended to be a resource for physicians and other health care professionals who provide care and treatment to patients with multidrug-resistant tuberculosis in DOTS-Plus projects in resource-poor areas.

A DOTS-Plus Handbook – Guide to the Community-Based Treatment of MDR TB
by Partners In Health, Harvard Medical School, and the Bill and Melinda Gates Foundation (2002)

The Global Impact of Drug-Resistant Tuberculosis
Harvard Medical School, Open Society Institute

Research articles

Implementation of a rapid method for detection of resistance of M. tuberculosis to isoniazid and rifampin in a large-scale programmatic setting in Lima, Peru
Asencios L, Shin S, Han L, Llanos F, Stowell M, Sloutsky A.
International Journal of Tuberculosis and Lung Disease, in press.

Representative drug-susceptibility patterns for guiding design of retreatment regimens for MDR-TB
Rich ML, Socci AR, Mitnick CD, Nardell EA, Becerra MC, Bonilla C, Bayona J, Seung KJ, Furin JJ, Farmer PE, Mukherjee JS
International Journal of Tuberculosis and Lung Disease. 2006

MDR-TB retreatment regimens: design guidance from drug susceptibility patterns in representative local patient populations
Rich ML, Socci AR, Mitnick CD, Nardell EA, Becerra MC, Bonilla C, Bayona J, Seung KJ, Farmer PE, Mukherjee JS
International Journal of Tuberculosis and Lung Disease. 2006;10(3):290-296

Long-term follow-up for multidrug-resistant tuberculosis
Shin SS, Furin JJ, Alcantara F, Bayona J, Sanchez E, Mitnick CD.
Emerging Infectious Diseases. 2006;12(4):687-688.

Surgical therapy for patients with drug-resistant tuberculosis: report of 121 cases receiving community- based treatment in Lima, Peru
Somocurcio J, Sotomayor A, Shin S, Portilla S, Valcarcel M, Guerra D, Furin JJ.
Thorax. 2006

Validation of a rapid method for detection of M. tuberculosis resistance to isoniazid and rifampin in Lima, Peru
Solis L, Shin SS, Han LL, Llanos F, Stowell M, Sloutsky A
International Journal of Tuberculosis and Lung Disease. 2005;9(7):760-764

Drug-resistance profiles of Mycobacterium tuberculosis isolates: Five years experience and insight into treatment strategies for multidrug resistant tuberculosis in Lima, Peru
Timperi R, Han LL, Sloutsky A, Becerra MC, Nardell EA, Salazar JJ, Smith-Fawzi MC
International Journal of Tuberculosis and Lung Disease. 2005;9(2):175-180

Re-treatment management strategies when first-line tuberculosis therapy fails
Saravia JC, Appleton SC, Rich ML, Sarria M, Bayona J, Becerra MC
International Journal of Tuberculosis and Lung Disease. 2005;9(4):421-429

M. rpoB gene mutations in clinical isolates in multidrug-resistant Mycobacterium tuberculosis in Northern Lima, Peru
Shin S, Naroditskaya V, Sloutsky A, Werner B, Timperi R, Bayona J, Farmer P, Becerra
Microbial Drug Resistance. 2005;11(1):26-30

Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of six children with intrauterine exposure to second-line agents
Drobac PC, del Castillo H, Sweetland A, Anca G, Joseph J, Furin, Shin S
Clinical Infectious Diseases. 2005;40(11):1689-1692.

Community-based therapy for children with multidrug-resistant tuberculosis
Drobac PC, Mukherjee JS, Joseph JK, Mitnick C, Furin JJ, del Castillo H, Shin SS, Becerra MC
Pediatrics. 2006;117(6):2022-2029

Disintegrating Health Services and Resurgent Tuberculosis in Post-Soviet Tajikistan:
An Example of Structural Violence

Keshavjee S, Becerra M.
Journal of the American Medical Association, March 1, 2000, Vol. 283:9, 1201

Treatment Outcomes in an Integrated Civilian and Prison Multidrug-resistant Tuberculosis Treatment Program in Russia
Shin S S, Pasechnikov A D, Gelmanova I Y, Peremitin G G, Strelis A K, Andreev Y G, Golubchikova V T, Tonkel T P, Yanova G V, Nikiforov M, Yedilbayev A, Mukherjee J S, Furin J J, Barry D J, Farmer P E, Rich M L, Keshavjee S
International Journal of Tuberculosis and Lung Disease, April 2006, Vol. 10(4): 402-408.

Causes of death during tuberculosis treatment in Tomsk Oblast, Russia
Mathew TA, Ovsyanikova TN, Shin SS, Gelmanova I, Balbuena DA, Atwood S, Peremitin GG, Strelis AK, Murray MB. International Journal of Tuberculosis and Lung Disease. 2006;10(8):857-863.

Multidrug-resistant tuberculosis in urban Rwanda: a case series of highly resistant tuberculosis from a public hospital in Kigali
Furin JJ, Mitnick CD, Mukherjee J, Sloutsky A, Epino H, Stulac S, Drobac P, Farmer PE, Rich ML
East African Medical Journal. 2006, in press




TUBERCULOSIS UPDATE


New guidelines and goals for treatment of MDR-TB
TB GuidelinesNew guidelines for treating multi-drug resistant tuberculosis (MDR-TB) were announced at a gathering of TB experts in Atlanta on May 10. The strategy endorses the goal of increasing the number of MDR-TB patients receiving treatment 50-fold over the next decade.

 

COPYRIGHT © 2006 PARTNERS IN HEALTH. ALL RIGHTS RESERVED.
Legal Terms of Use / Privacy Policy